Neuraxis, INC (NRXS) · Oct 14, 2026 · Other events
Stock dividend declared — ~81,339 common shares at $2.38 per share
NeurAxis declared its quarterly preferred-stock dividend in common shares. The payment avoids cash outflow but adds modest, expected dilution.
NeurAxis is commercializing neuromodulation devices, including IB-Stim and RED, while trying to expand insurance coverage and fund operations during a still-loss-making growth phase.
This is a routine quarterly obligation, not a new strategic signal. The board declared the Series B preferred-stock dividend for the third quarter, payable October 30 to holders of record October 26. 〔0〕 The company has already established that these preferred shares accrue an 8.5% annual cumulative dividend through December 31, 2026, payable in cash or common shares at its discretion.
| Item | Third-quarter dividend |
|---|---|
| Settlement | Common stock |
| Shares expected | Approximately 81,339 |
| Conversion price | $2.38 per share |
| Record date | October 26, 2026 |
| Payment date | October 30, 2026 |
The trade-off is clear: preserved cash, incremental dilution. Paying in shares avoids a cash payment at a company that reported substantial doubt about its ability to continue as a going concern and expects to need working capital through 2026 and beyond. But the issuance adds roughly 81,000 shares to the common-stock base; that is modest relative to the approximately 12.6 million common shares outstanding as of August 6, 2026. 〔1〕
Bottom line: This filing keeps NeurAxis’s existing financing pattern intact: no immediate cash drain, but recurring dilution. It matters for capital structure, not for the underlying device-commercialization story, and the event was already largely expected.
Dividend payment on October 30, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!